Loading...
XHKG
1112
Market cap809mUSD
Apr 11, Last price  
9.73HKD
1D
11.07%
1Q
18.95%
Jan 2017
-59.37%
IPO
-11.38%
Name

Health And Happines(H&H)Intrntnl Hds Ltd

Chart & Performance

D1W1MN
P/E
10.15
P/S
0.42
EPS
0.90
Div Yield, %
4.93%
Shrs. gr., 5y
-0.17%
Rev. gr., 5y
6.57%
Revenues
13.05b
-6.28%
558,969,0001,233,560,0002,189,034,0003,381,901,0004,561,299,0004,731,563,0004,818,561,0006,505,616,0008,095,345,00010,132,498,00010,925,217,00011,194,679,00011,547,825,00012,775,914,00013,926,470,00013,051,708,000
Net income
-54m
L
108,317,000265,683,000527,351,000743,106,000820,715,000806,786,000251,461,000954,396,000932,846,000843,148,0001,005,049,0001,136,694,000508,484,000611,783,000581,845,000-53,721,000
CFO
1.35b
+22.76%
109,798,000381,012,000516,212,000947,182,000660,473,000972,172,000365,732,0001,543,193,0001,950,814,0001,697,212,0001,439,243,0001,532,552,0001,890,080,0001,469,313,0001,096,819,0001,346,423,000
Dividend
Sep 10, 20240.3 HKD/sh
Earnings
May 08, 2025

Profile

Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells family nutrition and baby care products worldwide. The company's Infant Formulas segment produces infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. Its Probiotic Supplements segment offers probiotic supplements in the form of sachets, capsules, and tablets for infants, children, and expectant mothers. The company's Adult Nutrition and Care Products segment produces vitamins, health supplements, and skincare and sports nutrition products for adults. Its Other Pediatric Products segment produces dried baby food and nutrition supplements, and baby care products. The company's Pet Nutrition and Care products segment produces food, health supplements, and bone broth products for pets. It is also involved in the research, development, and processing of meat, fruit, and vegetable powder and candy; research, development, manufacture, and sale of special nutritional foods; marketing and distribution of organic baby foods; and wholesale, retail, import, and export of nutritional food and personal care products for infants. In addition, the company engages in the trading and sale of vitamins, health supplements, probiotic skin care, and sports nutrition products for adults; and provision of online sales, software, and information technology services, as well as packaging services. It provides its products under the Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII brands. The company was formerly known as Biostime International Holdings Limited and changed its name to Health and Happiness (H&H) International Holdings Limited in June 2017. The company was founded in 1999 and is headquartered in Quarry Bay, Hong Kong. Health and Happiness (H&H) International Holdings Limited is a subsidiary of Biostime Pharmaceuticals (China) Limited.
URL
http://www.hh.global
IPO date
Dec 17, 2010
Employees
3,372
Domiciled in
HK
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
13,051,708
-6.28%
13,926,470
9.01%
12,775,914
10.63%
Cost of revenue
11,485,198
12,094,124
11,193,530
Unusual Expense (Income)
NOPBT
1,566,510
1,832,346
1,582,384
NOPBT Margin
12.00%
13.16%
12.39%
Operating Taxes
250,514
351,757
419,148
Tax Rate
15.99%
19.20%
26.49%
NOPAT
1,315,996
1,480,589
1,163,236
Net income
(53,721)
-109.23%
581,845
-4.89%
611,783
20.32%
Dividends
(281,908)
(474,529)
(233,623)
Dividend yield
4.97%
6.04%
2.18%
Proceeds from repurchase of equity
(118,677)
BB yield
1.11%
Debt
Debt current
889,684
4,759,559
1,008,613
Long-term debt
8,545,041
4,570,052
8,761,965
Deferred revenue
Other long-term liabilities
2,069
842,563
189,036
Net debt
7,830,805
7,543,692
7,045,537
Cash flow
Cash from operating activities
1,346,423
1,096,819
1,469,313
CAPEX
(56,658)
(58,067)
(102,493)
Cash from investing activities
895
(52,071)
(104,876)
Cash from financing activities
(1,070,999)
(1,994,607)
(1,489,801)
FCF
1,369,469
1,371,360
1,221,429
Balance
Cash
1,603,920
1,448,611
2,303,660
Long term investments
337,308
421,381
Excess cash
951,335
1,089,596
2,086,245
Stockholders' equity
6,465,538
5,573,146
7,082,409
Invested Capital
14,223,947
15,270,744
13,594,648
ROIC
8.92%
10.26%
8.69%
ROCE
9.88%
11.20%
9.58%
EV
Common stock shares outstanding
641,275
644,867
644,323
Price
8.85
-27.34%
12.18
-26.89%
16.66
37.91%
Market cap
5,675,287
-27.74%
7,854,479
-26.83%
10,734,416
37.63%
EV
13,506,092
15,398,171
19,442,587
EBITDA
1,867,502
2,134,599
1,893,667
EV/EBITDA
7.23
7.21
10.27
Interest
869,868
807,605
530,292
Interest/NOPBT
55.53%
44.07%
33.51%